CytRx Corp. (CYTR) Stock Quote

Detailed Quote for CytRx Corp. (CYTR)

close 52 Week Information

52 Week High

April 28, 2011

Close: 1.06

52 Week Low

December 16, 2011

Close: 0.24

Today

5d

1m

3m

1y

more

Last Price
0.3648

Change $
0.0098

Change %
2.76%

Tick

Bid
0.3632

Bid Size
500

Ask
0.3648

Ask Size
100

Open
0.3694

High
0.38

Low
0.3475

Prev Close
0.355

Last Trade
2:13

Volume
1.91 m

52 Wk Hi
1.06

52 Wk Low
0.24

Market Cap
54.15 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
148,427,069

EPS (TTM)
-0.04

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Small Caps (NSC) Exchange
NSC

News and Media for CytRx Corp. (CYTR)

Sector News | Topic News

News for CYTR

Mon, Feb 06, 2012

8:30 AM

CytRx to Present at BIO CEO & Investor Conference - Business Wire

Thu, Dec 22, 2011

8:30 AM

CytRx Initiates International Phase 2b Clinical Trial with INNO-206 in Advanced Soft Tissue Sarcoma - Business Wire

Mon, Dec 12, 2011

8:30 AM

CytRx Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at ASH Conference - Business Wire

Wed, Nov 02, 2011

8:16 AM

Faster FDA Drug Reviews Should Benefit Cardium Therapeutics and CytRx Corporation - Marketwire

Thu, Jul 14, 2011

8:16 AM

Pipelines and Patents Continue to Drive the Biotech Sector - Marketwire

Wed, Dec 02, 2009

10:56 AM

CytRx Corporation (NASDAQ:CYTR) Shaping Up To Be A Winner - Accesswire

10:56 AM

CytRx Corporation (NASDAQ:CYTR) Shaping Up To Be A Winner - Accesswire

More News for CYTR >>

Tags for CytRx Corp.

Research stocks or mutual funds related to CytRx Corp. by keywords or tags. Find companies that have a similar focus to CYTR. The keywords below have been associated to CYTR by either user submission or electronic means.

northland corporation bancamerica securities biotech research investor relations company pharmaceutical market Commercial Physical And Biological Research (8731) pharmaceuticals companies generic pharmaceutical financial investment service pharmaceutical investment investor relations consultants financial securities pharmaceutical research and development Not Elsewhere Classified (7389) financial investments pharmaceutical manufacturing company investments advisors dupont pharmaceuticals Biological Products pharmaceutical industry marketing advisors taylor investment advisors pharmaceutical software pharma manufacturing pharma license investment financial group pharmaceutical cro pharma companies franklin llc pharmaceutical distributors investments investment advisors biotech corporation financial services company pharmaceutical reports noble corporation pharmaceutical consultant Drugs pharmaceutical auctions financial investment firms pharmaceutical manufacturing software pharmaceutical manufacturing financial consultants pharmaceutical formulation contract pharmaceutical pharmaceutical consulting pharmaceutical industry pharmaceutical studies pharmaceutical advances pharmaceutical distributor

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.